Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women.

Source:http://linkedlifedata.com/resource/pubmed/id/19282307

Download in:

View as

General Info

PMID
19282307